|
US2020331896A1
|
|
Compounds and methods for the treatment of ocular disorders
|
|
WO2020212755A1
|
|
Compounds and methods for the treatment of ocular disorders
|
|
WO2020212760A2
|
|
Compounds and methods for the treatment of ocular disorders
|
|
WO2020208418A1
|
|
Compositions and methods for the treatment of contact lens discomfort
|
|
WO2020030975A2
|
|
Dispenser for precise extraction of a semi-solid product
|
|
MX2019011697A
|
|
Agents for increasing meibomian gland lipid secretion.
|
|
EP3445352A2
|
|
Compositions for the treatment of hyperkeratosis disorders
|
|
KR20180129920A
|
|
Selenium disulfide composition for use in the treatment of myalgia
|
|
AU2016332966A1
|
|
Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion
|
